British Association for Psychopharmacology / BAP Consensus Guidelines

2009年のガイドライン

「antidepressants.pdf」

「ADHD_Guidelines.pdf」

「Anxiety_Disorder_Guidelines.pdf」

「BAP_Sleep_Guidelines.pdf」

「Bipolar_guidelines.pdf」

「Schizophrenia_Consensus_Guideline_Document.pdf」

たとえば Antidepressants の要点としては

Efficacy considerations

Summary

Antidepressant class: Antidepressant drugs have similar efficacy

in first line use for the majority of patients with depression (I).

In hospitalised patients amitriptyline may be marginally more

effective than other TCAs/ SSRIs, and older monoamine oxidase

inhibitors (MAOIs) may be less effective than imipramine (I).

Venlafaxine and escitalopram appear to be marginally more

effective than other SSRIs (I). For escitalopram at a dose of

20 mg this may be to a clinically significant degree for severely

ill patients (II).